Needham & Company analyst Mike Matson raised the price target on Globus Medical (NYSE: GMED) to $82.00 (from $75.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Globus Medical (GMED) PT Raised to $73 at StifelMay 5, 2021 9:36 AM Globus Medical (GMED) PT Raised to $78 at Wells FargoMay 5, 2021 6:21 AM Globus Medical (GMED) PT Raised to $81 at CitiMay 5, 2021 5:29 AM Globus Medical (GMED) PT Raised to $81 at BTIGMay 5, 2021 5:18 AM Globus Medical (GMED) PT Raised to $77 at Morgan StanleyMay 5, 2021 4:36 AM Globus Medical (GMED) Tops Q1 EPS by 12c, Offers GuidanceMay 4, 2021 4:43 PM Form 10-Q GLOBUS MEDICAL INC For: Mar 31May 4, 2021 4:28 PM Form 8-K GLOBUS MEDICAL INC For: May 04May 4, 2021 4:21 PM